23 Publikationen

Alle markieren

[23]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935652
J. Witte, et al., “Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.”, Annals of oncology : official journal of the European Society for Medical Oncology, 2019.
PUB | DOI | WoS | PubMed | Europe PMC
 
[22]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936903 OA
S. Scholz, et al., “Epidemiology and cost of seasonal influenza in Germany - a claims data analysis”, BMC public health, vol. 19, 2019, : 1090.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[21]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934071 OA
S. Scholz, et al., “Population size and self-reported characteristics and sexual preferences of men-who-have-sex-with-men (MSM) in Germany based on social network data”, PLOS ONE, vol. 14, 2019, : 0212175.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[20]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934052
S. Sheikh, et al., “Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].”, Vaccine, vol. 37, 2019, pp. 1374-1376.
PUB | DOI | WoS | PubMed | Europe PMC
 
[19]
2018 | Bielefelder E-Dissertation | PUB-ID: 2932490 OA
O. Damm, Die Anwendung von Modellierungsmethoden im Rahmen der gesundheitsökonomischen Evaluation von Impfungen in Deutschland, Bielefeld: Universität Bielefeld, 2018.
PUB | PDF | DOI
 
[18]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2931114
S. Sheikh, et al., “A report on the status of vaccination in Europe”, VACCINE, vol. 36, 2018, pp. 4979-4992.
PUB | DOI | WoS | PubMed | Europe PMC
 
[17]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2917041
J. Horn, et al., “Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study”, BMC MEDICINE, vol. 16, 2018, : 9.
PUB | DOI | WoS | PubMed | Europe PMC
 
[16]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2914076 OA
O. Damm, et al., “Cost-effectiveness of human papillomavirus vaccination in Germany”, Cost Effectiveness and Resource Allocation, vol. 15, 2017, : 18.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[15]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2911011
L. Gerlier, et al., “Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model”, APPLIED HEALTH ECONOMICS AND HEALTH POLICY, vol. 15, 2017, pp. 261-276.
PUB | DOI | WoS | PubMed | Europe PMC
 
[14]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916591
P.T. de Boer, et al., “A systematic review of the health economic consequences of quadrivalent influenza vaccination”, Expert Review of Pharmacoeconomics & Outcomes Research, vol. 17, 2017, pp. 249-265.
PUB | DOI | WoS | PubMed | Europe PMC
 
[13]
2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2905960
O. Damm, et al., “Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review”, INTERNATIONAL JOURNAL OF PUBLIC HEALTH, vol. 61, 2016, pp. 847-860.
PUB | DOI | WoS | PubMed | Europe PMC
 
[12]
2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2902118
B. Ultsch, et al., “Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community”, PHARMACOECONOMICS, vol. 34, 2016, pp. 227-244.
PUB | DOI | WoS | PubMed | Europe PMC
 
[11]
2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2906732
L. Gerlier, et al., “Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium”, PEDIATRIC DRUGS, vol. 18, 2016, pp. 303-318.
PUB | DOI | WoS | PubMed | Europe PMC
 
[10]
2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2758733 OA
O. Damm, et al., “Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.”, BMC Public Health, vol. 15, 2015, : 533.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[9]
2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2917091
O. Damm and B. Ultsch, “Gesundheitsökonomische Evaluation von Impfungen”, Gesundheitsökonomie & Qualitätsmanagement, vol. 20, 2015, pp. 163-172.
PUB | DOI | WoS
 
[8]
2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2758642
O. Damm, et al., “Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany”, The European Journal of Health Economics, vol. 16, 2015, pp. 471-488.
PUB | DOI | WoS | PubMed | Europe PMC
 
[7]
2014 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2661294 OA
M.A. Rose, et al., “The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study”, BMC Infectious Diseases, vol. 14, 2014, pp. 40.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[6]
2013 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2607268
J. Horn, et al., “Estimating the long-term effects of HPV vaccination in Germany”, Vaccine, vol. 31, 2013, pp. 2372-2380.
PUB | DOI | WoS | PubMed | Europe PMC
 
[5]
2013 | Report | PUB-ID: 2686145 OA
J. Horn, et al., Langfristige epidemiologische und ökonomische Auswirkungen der HPV-Impfung in Deutschland. Überarbeiteter Abschlussbericht, Berlin: Robert Koch-Institut, 2013.
PUB | PDF
 
[4]
2012 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2553505
O. Damm, F. Leppert, and W. Greiner, “Cost of illness of common cancer types - Results of a health insurance claims data analysis”, Value In Health, vol. 15, 2012, pp. A417-A417.
PUB | DOI | WoS
 
[3]
2012 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2474515
R.T. Mikolajczyk, et al., “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”, JNCI Journal of the National Cancer Institute, vol. 104, 2012, pp. 163.
PUB | DOI | WoS | PubMed | Europe PMC
 
[2]
2012 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2530533
J. Breckenkamp, et al., “Abgleich von Verwaltungsdaten des Medizinischen Dienstes der Krankenversicherung mit Krebsregisterdaten”, Das Gesundheitswesen, vol. 74, 2012, pp. e52-e60.
PUB | DOI | WoS | PubMed | Europe PMC
 
[1]
2009 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 1589642
O. Damm and W. Greiner, “COST-EFFECTIVENESS OF HPV VACCINATION-AN OVERVIEW ON INTERNATIONAL STUDY RESULTS”, VALUE IN HEALTH, vol. 12, 2009, pp. A277.
PUB | DOI | WoS
 

Suche

Publikationen filtern

Darstellung / Sortierung

Zitationsstil: ieee

Export / Einbettung

23 Publikationen

Alle markieren

[23]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935652
J. Witte, et al., “Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.”, Annals of oncology : official journal of the European Society for Medical Oncology, 2019.
PUB | DOI | WoS | PubMed | Europe PMC
 
[22]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936903 OA
S. Scholz, et al., “Epidemiology and cost of seasonal influenza in Germany - a claims data analysis”, BMC public health, vol. 19, 2019, : 1090.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[21]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934071 OA
S. Scholz, et al., “Population size and self-reported characteristics and sexual preferences of men-who-have-sex-with-men (MSM) in Germany based on social network data”, PLOS ONE, vol. 14, 2019, : 0212175.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[20]
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934052
S. Sheikh, et al., “Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].”, Vaccine, vol. 37, 2019, pp. 1374-1376.
PUB | DOI | WoS | PubMed | Europe PMC
 
[19]
2018 | Bielefelder E-Dissertation | PUB-ID: 2932490 OA
O. Damm, Die Anwendung von Modellierungsmethoden im Rahmen der gesundheitsökonomischen Evaluation von Impfungen in Deutschland, Bielefeld: Universität Bielefeld, 2018.
PUB | PDF | DOI
 
[18]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2931114
S. Sheikh, et al., “A report on the status of vaccination in Europe”, VACCINE, vol. 36, 2018, pp. 4979-4992.
PUB | DOI | WoS | PubMed | Europe PMC
 
[17]
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2917041
J. Horn, et al., “Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study”, BMC MEDICINE, vol. 16, 2018, : 9.
PUB | DOI | WoS | PubMed | Europe PMC
 
[16]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2914076 OA
O. Damm, et al., “Cost-effectiveness of human papillomavirus vaccination in Germany”, Cost Effectiveness and Resource Allocation, vol. 15, 2017, : 18.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[15]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2911011
L. Gerlier, et al., “Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model”, APPLIED HEALTH ECONOMICS AND HEALTH POLICY, vol. 15, 2017, pp. 261-276.
PUB | DOI | WoS | PubMed | Europe PMC
 
[14]
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916591
P.T. de Boer, et al., “A systematic review of the health economic consequences of quadrivalent influenza vaccination”, Expert Review of Pharmacoeconomics & Outcomes Research, vol. 17, 2017, pp. 249-265.
PUB | DOI | WoS | PubMed | Europe PMC
 
[13]
2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2905960
O. Damm, et al., “Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review”, INTERNATIONAL JOURNAL OF PUBLIC HEALTH, vol. 61, 2016, pp. 847-860.
PUB | DOI | WoS | PubMed | Europe PMC
 
[12]
2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2902118
B. Ultsch, et al., “Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community”, PHARMACOECONOMICS, vol. 34, 2016, pp. 227-244.
PUB | DOI | WoS | PubMed | Europe PMC
 
[11]
2016 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2906732
L. Gerlier, et al., “Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium”, PEDIATRIC DRUGS, vol. 18, 2016, pp. 303-318.
PUB | DOI | WoS | PubMed | Europe PMC
 
[10]
2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2758733 OA
O. Damm, et al., “Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.”, BMC Public Health, vol. 15, 2015, : 533.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[9]
2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2917091
O. Damm and B. Ultsch, “Gesundheitsökonomische Evaluation von Impfungen”, Gesundheitsökonomie & Qualitätsmanagement, vol. 20, 2015, pp. 163-172.
PUB | DOI | WoS
 
[8]
2015 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2758642
O. Damm, et al., “Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany”, The European Journal of Health Economics, vol. 16, 2015, pp. 471-488.
PUB | DOI | WoS | PubMed | Europe PMC
 
[7]
2014 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2661294 OA
M.A. Rose, et al., “The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study”, BMC Infectious Diseases, vol. 14, 2014, pp. 40.
PUB | PDF | DOI | WoS | PubMed | Europe PMC
 
[6]
2013 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2607268
J. Horn, et al., “Estimating the long-term effects of HPV vaccination in Germany”, Vaccine, vol. 31, 2013, pp. 2372-2380.
PUB | DOI | WoS | PubMed | Europe PMC
 
[5]
2013 | Report | PUB-ID: 2686145 OA
J. Horn, et al., Langfristige epidemiologische und ökonomische Auswirkungen der HPV-Impfung in Deutschland. Überarbeiteter Abschlussbericht, Berlin: Robert Koch-Institut, 2013.
PUB | PDF
 
[4]
2012 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2553505
O. Damm, F. Leppert, and W. Greiner, “Cost of illness of common cancer types - Results of a health insurance claims data analysis”, Value In Health, vol. 15, 2012, pp. A417-A417.
PUB | DOI | WoS
 
[3]
2012 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2474515
R.T. Mikolajczyk, et al., “Re: Epidemiological Study of Anti-HPV16/18 Seropositivity and Subsequent Risk of HPV16 and-18 Infections”, JNCI Journal of the National Cancer Institute, vol. 104, 2012, pp. 163.
PUB | DOI | WoS | PubMed | Europe PMC
 
[2]
2012 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2530533
J. Breckenkamp, et al., “Abgleich von Verwaltungsdaten des Medizinischen Dienstes der Krankenversicherung mit Krebsregisterdaten”, Das Gesundheitswesen, vol. 74, 2012, pp. e52-e60.
PUB | DOI | WoS | PubMed | Europe PMC
 
[1]
2009 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 1589642
O. Damm and W. Greiner, “COST-EFFECTIVENESS OF HPV VACCINATION-AN OVERVIEW ON INTERNATIONAL STUDY RESULTS”, VALUE IN HEALTH, vol. 12, 2009, pp. A277.
PUB | DOI | WoS
 

Suche

Publikationen filtern

Darstellung / Sortierung

Zitationsstil: ieee

Export / Einbettung